Abstract Cells in multicellular organisms are surrounded by a complex three-dimensional macromolecular extracellular matrix (ECM). This matrix, traditionally thought to serve a structural function providing support and strength to cells within tissues, is increasingly being recognized as having pleiotropic effects in development and growth. Elucidation of the role that the ECM plays in developmental processes has been significantly advanced by studying the phenotypic and developmental consequences of specific genetic alterations of ECM components in the mouse. These studies have revealed the enormous contribution of the ECM to the regulation of key processes in morphogenesis and organogenesis, such as cell adhesion, proliferation, specification, migration, survival, and differentiation. The ECM interacts with signaling molecules and morphogens thereby modulating their activities. This review considers these advances in our understanding of the function of ECM proteins during development, extending beyond their structural capacity, to embrace their new roles in intercellula signaling.
Structurally, the unique architecture and characteristics of tissues and organs are determined by the extracellular matrix (ECM) and the cells that produce it. ECM proteins can be classified into four general categories: collagens, structural glycoproteins, proteoglycans, and elastins. Within the ECM, the components assemble into macromolecular superstructures such as collagen fibrils, elastic fibers, and microfibrils, which interact with a plethora of other ECM proteins, such as proteoglycans and structural glycoproteins to form diverse connective tissues such as basement membranes and tendons (for more details of these basic molecules and structures please refer to Box 1 and other reviews in this issue). The ECM is ancient. The existence of collagens in all metazoans including primitive sponges with simple epithelia implicates the ECM in the evolution and diversification of tissue differentiation (Aouacheria et al. 2006) . Indeed, the diversity present within the ECM produces the spectrum of structural characteristics of the various connective tissues and organs.
Gene alterations in animal model systems have revealed that specific ECM components are indispensable for development (Table 1) , with roles other than those for mechanical support (Fig. 1) . Insights into the structure and assembly of ECM proteins from various in vitro and in vivo studies have established the framework to improve our understanding of the biological function of these components in development. Interestingly, these studies have demonstrated many examples of ECM involvement in signal transduction, changing our traditional view of ECM proteins as passive space fillers. The ECM undergoes constant remodeling and, through its intimate interaction with cells, modulates the transduction of signals that regulate differentiation, proliferation, and cell death. In Table 1 Examples of extracellular matrix (ECM) components required for proper developmental processes in mouse (BM basement membrane, KO knock-out by gene targeting, CKO tissuespecific conditional knock-out, dKO double-gene knock-out, NM natural mutations, L lethal, TG transgenic, V viable, CNS central nervous system, IHH Indian hedgehog, FGF fibroblast growth factor); for an extensive list of gene targeting and natural mutants, see Aszodi et al. Formation of embryonic BM in peri-implantation embryo Smyth et al. 1999 Neural crest migration and neural differentiation Agrin (Agrn KO and TG; L) Development of the neuromuscular junctions and CNS synapses Gautam et al. 1996; Ksiazek et al. 2007 Fibronectin (Fn1 KO; L)
Proper formation of neural tube George et al. 1993 Laminin α5 (lama5 KO; L)
Neural tube closure and neural crest cell migration Miner et al. 1998; Coles et al. 2006 Laminin β2 (lamb2 KO; L)
Development of the neuromuscular junctions and CNS synapses Libby et al. 1999; Noakes et al. 1995a Laminin γ1 (Lamc1 CKO)
Schwann cell proliferation and differentiation, and axon myelination Chen and Strickland 2003; Yu et al. 2005 Notochord development Collagen II (Col2a1 KO; L)
Remodeling of notochord during intervertebral disc formation Aszodi et al. 1998 Fibronectin (Fn1 KO)
Formation of notochord and somites George et al. 1993 Chondrogenesis Aggrecan (Acan NM; L)
Structural integrity of cartilage and endochondral bone formation; modulates IHH diffusion Watanabe et al. 1994; Cortes et al. 2009 Collagen II and XI (Col2a1 KO and Col11a1 NM; L; Col11a2 KO; V)
Structural integrity of cartilage and endochondral bone formation S.W. Li et al. , 2001 ; Y. Link protein (Hapln1 KO; L)
Stabilizing interaction between aggrecan and hyaluronan Watanabe and Yamada 1999 Perlecan (Hspg2 KO; L)
Structural integrity of cartilage and endochondral bone formation; modulate FGF signaling Arikawa-Hirasawa et al. 1999; Costell et al. 1999 Skin development Collagen III and V (Col3a1 KO and Col5a1 KO; L), decorin and lumican (Dcn KO and Lum KO; V)
Regulation of collagen fibril assembly in the dermis for mechanical strength and resilience of the skin Liu et al. 1997; Andrikopoulos et al. 1995; Danielson et al. 1997; Chakravarti et al. 1998 Laminin α5 (lama5 KO; L)
Hair follicle morphogenesis J. Li et al. 2003 Nephrogenesis Laminin α3, α5 and β2 (lama3 KO, lama5 KO and lamb2 KO; L)
Glomerulogenesis Abrass et al. 2006; Miner and Li 2000; Noakes et al. 1995b Nephronectin (Npnt KO; L)
Mediate kidney organogenesis Linton et al. 2007 Stem cell niche formation and maintenance Biglycan and fibromodulin (Bgn/Fmod dKO)
Regulation of the differentiation of tendon stem/progenitor cells for tendon development and formation Bi et al. 2007 Biglycan and decorin (Bgn/Dcn dKO)
Regulation of differentiation and survival of osteoprogenitors Bi et al. 2005 Collagen X (Col10a1 KO and TG) Contribution to the formation of hematopoietic stem cell niche Sweeney et al. 2008 morphogenesis and organogenesis, the ECM integrates spatio-temporal cues in a three-dimensional structure involving multiple cell types. In vivo studies of defined alterations of ECM components in animal model systems are important means to further our appreciation of ECM function. Over the last two decades, researchers have used complementary model organisms to study genes and signaling pathways in specific developmental processes. Nematode worms (Caenorhabditis elegans), fruit flies (various Drosophilia species), zebrafish (Danio rerio), frogs (Xenopus laevis and tropicalis), chicken (Gallus gallus), and mouse (Mus musculus) have all contributed significantly to our knowledge of ECM gene function. Each model organism has distinct attributes for the study of a developmental process or for certain genetic manipulations, often with surprising findings such as unexpected genetic interaction or redundancy.
In the mouse, recent technical advances in the conditional manipulation of genes by using a drug-inducible Cre-loxP system not only have provided a means to overcome the problem of embryonic lethality, but have also allowed researchers to address cell/tissue-specific functions of ECM genes at selected stages of development and growth. Important lessons and new paradigms are emerging from these studies, which provide new insights into the importance of cell-ECM interactions and the role of the ECM in modulating signaling during tissue morphogenesis and development. A recent review has provided an excellent overview of ECM function derived from studies of mouse models with alterations in various ECM proteins (Aszodi et al. 2006) . In this review, we will discuss recent advances in our understanding of the roles of ECM proteins in modulating signaling activities for the proper progression of developmental processes, in addition to "traditional" structural roles.
Development depends on ECM structural integrity
The ECM is crucial even before fertilization takes place. The zona pellucida of mouse oocyte, a thick matrix made of three glycoproteins (ZP1, ZP2, ZP3), is indispensable for oocyte maturation and fertilization (Wassarman et al. 2004; Monne et al. 2008) . During the course of development, ECM composition and organization are strictly regulated and modified to modulate tissue morphogenesis and organogenesis; abnormalities in the ECM often lead to developmental defects and/or lethality (Table 1) .
Early embryonic development requires a proper basement membrane
The basement membrane (BM) is a specialized sheet of ECM containing laminin, collagen IV, and heparan sulfate proteoglycan (HSPG). It provides structural support, acts as a selective barrier, and modulates signaling cues for adjacent cells (see also Box 1). It is first synthesized by the primitive endoderm and trophectoderm, in the periimplantation mouse embryo at the blastocyst stage. Laminin-111 (α1β1γ1) and laminin-511 (α5β1γ1) are the earliest isoforms found in embryonic BM, and the absence of both results in early lethality of mouse embryos with defects in primitive endoderm differentiation and epiblast polarization (Miner et al. 2004; Smyth et al. 1999) . The embryonic BM may also prevent the epiblast from differentiating precociously into mesoderm-like cells as occurs in embryoid bodies derived from embryonic stem cells of Lamc1 -/-embryos (Fujiwara et al. 2007 ). Nevertheless, laminin-111 and laminin-511 can partially compensate for each other, since embryos lacking either laminin-511 or laminin-111 survive for longer (Miner et al. 1998 (Miner et al. , 2004 . In the absence of laminin-111, Lama1
-/-embryos do not form a proper Reichert's membrane, a BM that separates embryonic and maternal tissues, and cannot initiate gastrulation resulting in lethality (Miner et al. 2004 ; Table 1 ). By contrast, Lama5
-/-embryos deficient in laminin-511 undergo gastrulation but develop severe defects in many organs (Miner et al. 1998 (Miner et al. , 2004 . Thus, laminin α1 and α5 chains have overlapping and also independent roles in many developmental processes (see also below).
Perlecan is a ubiquitous and multifunctional HSPG found in BM (Whitelock et al. 2008 ). Hspg2 -/-embryos that lack perlecan show a complex phenotype, with about half the embryos dying at around 10.5 days post-coitus (dpc) from defective myocardial BM (Costell et al. 1999; ArikawaHirasawa et al. 1999) . Interestingly, mice expressing perlecan with a reduced number of heparan sulfate side chains are viable and fertile but have small eyes and postnatal lens degeneration (Rossi et al. 2003) , suggesting that the core protein itself plays an important role in the ECM, or that the side chains share redundant functions.
Collagen IV is another major component of the BM and also the embryonic vasculature (Poschl et al. 2004 ) and is absolutely required for their structural stability and integrity. Whereas laminins can initiate BM assembly at periimplantation stages in the absence of collagen IV (Miner et al. 2004; Smyth et al. 1999; Poschl et al. 2004 ), the latter is required for conferring barrier functions and maintaining BM integrity associated with increasing mechanical demand as the embryos grow (Poschl et al. 2004) . Interestingly, mouse embryos lacking HSP47, a molecular chaperone that specifically assists collagen folding in the endoplasmic reticulum, exhibit disrupted BM structures associated with aberrant collagen IV synthesis (Nagai et al. 2000) . Similarly, defective collagen IV assembly, disruption of BMs, and embryonic lethality are also observed in mice lacking the collagen modification enzymes proline 4-hydroxylase α1 (encoded by P4ha1) or lysyl hydroxylase 1 (Plod1; Holster et al. 2007; Rautavuoma et al. 2004; Ruotsalainen et al. 2006) , highlighting that the intracellular synthesis and processing of collagens is crucial for the secretion of quality triple helix ready for proper ECM assembly, which ultimately determines the fate of the developing embryos. In humans, prolyl 3-hydroxylase 2 has recently been found to be important for modifying collagen IV of the BM in vitro (Tiainen et al. 2008 )}; whether this enzyme has an influence on early embryonic development remains to be tested in a knock-out mouse model.
These and other studies demonstrate that embryonic development requires a well-defined BM. Moreover, the recurrent use of these (and other) BM components in various anatomical sites implies that subtle structural variations of the ECM may be pivotal in generating the diverse tissue forms of an organism.
Tissue characteristics rely on collagen fibrillogenesis As organogenesis begins, the increasing complexity of tissue development requires diversified structural support that cannot be provided by a BM alone. In tissues/organs such as tendon, bone, cartilage, and skin, structural strength is contributed mainly by collagen fibrils composed of fibrillar collagens, including collagens I, III, and V (in most tissues) and collagens II and XI (in cartilage and the vitreous humor). Collagen fibrillogenesis is a multi-step process involving the assembly of individual collagen molecules into an intermediate form that then undergoes lateral and linear growth to become the mature fibril . ECM molecules, including fibronectin and small leucine-rich proteoglycans (SLRPs) such as decorin, biglycan, fibromodulin, and lumican, regulate fibrillogenesis. For example, corneal collagen fibrils do not undergo lateral growth but maintain a lumicandependent homogeneous distribution of small-diameter fibrils to favor transparency (Chakravarti et al. 2006) . In contrast, in tendon, fibromodulin promotes the maturation of small-diameter fibril intermediates (Ameye et al. 2002) into densely packed thick fiber bundles organized hierarchically to provide high tensile strength and to transmit forces (Banos et al. 2008 ). In the dermis, heterotypic collagen fibrils containing mainly collagens I, III, and V are the major structural components responsible for its characteristic strength and resilience. Defective fibrillogenesis can lead to severe skin abnormalities. Haploinsufficiency for the Col5a1 allele in mice results in impaired fibril nucleation and growth, leading to hyperextensible skin with reduced tensile strength resembling human EhlersDanlos syndrome . Although collagen V is a quantitatively minor fibrillar collagen, this example emphasizes that gene dosage is an important parameter for fibrillogenesis and indicates strict genetic control of proper ECM assembly during development. Fibrillogenesis in skin is also fine-tuned by the SLRPs decorin and lumican, which limit lateral growth of the fibril; mice lacking either of these SLRPs have increased fibril diameter in the dermis and fragile skin (Chakravarti et al. 1998; Danielson et al. 1997 ; Table 1 ). In the heart, fibrillar collagens have been implicated in ventricular myocardial morphogenesis and heart valve development (Peacock et al. 2008) , as shown in fetal mice deficient in collagens V and XI (Lincoln et al. 2006) . Therefore, tissue development and function relies on a structurally integral ECM formed by the proper assembly of its components.
ECM elasticity/stiffness influences cellular differentiation
The rigidity of a tissue depends on the composition of its ECM. Bone is stiff because of the extensive, highly crosslinked, collagen fibrils and matrix mineralization. Aorta, lung and skin can withstand repeated stretching because of the presence of elastic fibers (Wagenseil and Mecham 2007) . Recently, variation in ECM rigidity has been proposed to have additional important roles, such as directing stem cell lineage specification (Engler et al. 2006) and regulating the continuous beating of cardiomyocytes in culture (Engler et al. 2008) . Mesenchymal stem cells grown on soft gel differentiate into a neuronal-like lineage but, Fig. 1 Prototypic cell and extracellular matrix (ECM) interactions in various developmental scenarios. a In cartilage, the master transcriptional factor SOX9 specifies chondrocytic fate and activates transcription of cartilage ECM genes such as Col2a1, Col11a2, Col9a1, and Agc. Collagens II, IX, and XI form fibrils that might interact with β1 integrin to regulate chondrocyte proliferation and the architecture of growthplate cartilage. Indian hedgehog (IHH) expressed by prehypertrophic and hypertrophic chondrocytes regulates chondrocyte proliferation and differentiation in concert with bone formation. Its diffusion in the ECM is regulated by affinity with heparan sulfate proteoglycans (e.g., perlecan) and chondroitin sulfate proteoglycans (e.g., aggrecan). b ECM modulates morphogen signaling by interacting directly with bone morphogenetic protein (BMP) and fibroblast growth factor (FGF), which transduce signals through binding to and activating of their corresponding cell surface receptors. On the other hand, transforming growth factor β (TGFβ) signaling is regulated by tissue elasticity and cytoskeletal tension. TGFβ is bound to latency-associated protein and latent TGFβ-binding protein and then released when cytoskeletal tension and/or matrix structure changes. c A cell niche showing the various categories of ECM and signaling molecules present in the niche that help to maintain the cells in the stem/progenitor state and/or specifying cell fate. d Epithelial-mesenchymal interaction with reference to a recent model of hair follicle development. Laminin-511 secreted by epidermal cells acts as a paracrine factor to stimulate cilia formation on mesenchymal cells, thereby facilitating platelet-derived growth factor (PDGF) and sonic hedgehog (SHH) signaling and consequently Noggin expression. Noggin suppresses BMP signaling in the epidermal cell and promotes SHH expression, forming a positive feedback loop that supports hair follicle development when grown on a stiff gel, differentiate into the osteoblast lineage; gels of intermediate stiffness stimulate the cells to take on a myoblast phenotype (Engler et al. 2006) . The elasticity of the ECM acts in concert with cytoskeletal tension to regulate the release of soluble factors from the ECM, such as the release of TGFβ from integrin-bound latent TGFβ-binding protein-1 (Fig.1b) ; these factors then mediate cellular responses to direct cell-fate specification, tissue remodeling, and various developmental processes (Fontana et al. 2005; Wells and Discher 2008; Akimov and Belkin 2001) .
Developmental processes are regulated by ECM components
In developing vertebrates, the complex three-dimensional network of the ECM not only provides structural strength and integrity to various organs and tissues but also plays important functional roles in interacting with numerous growth factors and signaling molecules to regulate cellular events such as cell adhesion, proliferation, specification, migration, survival, and differentiation. The following section highlights some of the events mediated by the ECM as manifested in several developmental processes.
Role of the ECM in neural crest cell migration
Proper control of cell migration is essential for directing cells to their appropriate destinations in which they can differentiate into their target tissues during morphogenesis; the ECM provides the substratum on which this migration occurs. The neural crest of the vertebrate embryo, with its extensive migratory behavior and multipotency, has been one of the most powerful systems for the study of the role of the ECM in controlling cell migration, adhesion, differentiation, and growth. Neural crest cells arise from the dorsal tip of the neural tube, undergo an epithelial to mesenchymal transition during delamination, and then migrate along a stereotypical pathway to their destinations to generate many cell types throughout the embryo, notably neurons and glia of the peripheral and autonomic nervous system, the craniofacial skeleton, and skin melanocytes (Le Douarin 2001).
Most of the major ECM components are found in the interstices and/or BM along neural crest cell migratory routes (Newgreen and Thiery 1980; Krotoski and BronnerFraser 1986; Perris et al. 1991; Tucker and McKay 1991) . The spatial and temporal composition of the ECM provides both permissive and non-permissive guidance cues for neural crest migration. Several matrix glycoproteins have been shown to promote neural crest migration in vitro or in vivo in chick embryos, including fibronectin (Duband et al. 1986; Newgreen 1989) , laminin (Duband and Thiery 1987) , collagens I and IV (Perris et al. 1993a (Perris et al. , 1993b , and tenascin (Bronner-Fraser 1988; Tan et al. 1987) , whereas aggrecan, versican (Landolt et al. 1995; Perris et al. 1996) , and collagen IX (Ring et al. 1996) prevent the attachment and migration of neural crest cells. In contrast, functional ablation of some of these ECM components in mice does not significantly affect neural crest development, perhaps because compensation by other matrix molecules or subtype isoforms masks the phenotype. One exception is laminin-α5 knock-out mice, which show defects in neural crest migration and delay in gangliogenesis of the peripheral ganglia, suggesting a requirement of laminin-α5 chain for proper neural crest migration and timely differentiation (Coles et al. 2006) .
The ability of the ECM components to promote or inhibit neural crest migration is highly dependent on their native macromolecular structure and composition. The cell surface integrin family of receptors plays a predominant role in mediating neural crest migration through interaction with ECM molecules. Distinct mechanisms deployed by cranial and trunk neural crest cells in integrin regulation appear to confer their differential migratory behavior and cell fate in response to variations in substratum composition along the anterior-posterior axis (Lallier et al. 1992; Strachan and Condic 2003) . The presence of various integrin isoforms affects their ability to interact with specific matrix molecules to elicit downstream cellular events controlling adhesion, migration, proliferation, and survival (Delannet et al. 1994; Testaz and Duband 2001) .
Recent studies in Xenopus embryos have demonstrated that Syndecan-4, a cell surface HSPG that may serve as an ECM receptor, acts in a coordinated manner with planar cell polarity to control the directional migration of neural crest cells by regulating the activity of small GTPases (Matthews et al. 2008 ). In addition, fibronectin has been shown to promote neural crest differentiation along the smooth muscle lineage (Costa-Silva et al. 2009 ).
ECM organization and remodeling is required for notochord development
The notochord is an embryonic midline structure that plays an essential patterning role in development and that sends signals to the surrounding tissues with key roles in specifying ventral fates in the central nervous system (CNS) and in controlling left-right asymmetry (for a review, see Stemple 2005) . The notochord also plays an important structural role acting as the early axial skeleton of the embryo until the vertebrae form. Later in development, the notochord contributes to the center of the intervertebral discs in a structure called the nucleus pulposus. The notochord has also been proposed to participate in the segmental patterning of the vertebral column in which the vertebral bodies arise by secretion of cartilage matrix from the condensed mesenchyme surrounding the notochord. Notochord-derived signals are critical for the induction and patterning of the sclerotome, which gives rise to the vertebral body. Notochordal cells are surrounded by a rich ECM sheath composed of collagens II, IX, and XI, perlecan, and fibronectin (Gotz et al. 1995; Hayes et al. 2001) . Structural defects in the notochord may also impact on its function as a signaling center to pattern surrounding tissues. Consistent with the key role of the ECM for notochord function, inactivation of Col2a1, which encodes the α1(II) chain required for collagen II and XI assembly, results in the persistence of the notochord and defects in intervertebral disc formation (S.W. Aszodi et al. 1998) . Type II collagen is therefore essential for the proper remodeling of the notochord and formation of the intervertebral disc.
Several of the genes encoding these ECM components are directly regulated by the SOX transcription factors, SOX9, SOX5 and SOX6. SOX9 is required for maintaining the structural integrity of the notochord. The formation of the notochord sheath appears to be governed by SOX5 and SOX6 (Smits and Lefebvre 2003) . Genetic ablation of both Sox5 and Sox6 in the mouse has revealed that these genes play an important role in notochord development. Sox5 and Sox6 transcripts co-localize in notochord cells and surrounding sclerotome-derived cells. In Sox5/Sox6 doublemutants, the notochord is still generated, but expression of genes encoding ECM components such Col2a1, Agc, and Hspg2 are severely downregulated, resulting in the lack of ECM sheath formation. The mutant notochord cells subsequently undergo apoptosis, and the development of vertebral bodies is impaired (Smits and Lefebvre 2003) . Similarly in Sox9 null embryos, although a notochord is established, it disintegrates after embryonic day 9.5 (E9.5), and ECM genes that are SOX9-transcriptional targets including Col2a1 (Bell et al. 1997 ) and aggrecan (Acan; Han and Lefebvre 2008) are not expressed (Barrionuevo et al. 2006) . These functions of the notochord are probably mediated via cell-matrix interactions involving cell surface receptors such as integrins and fibronectin. Fibronectin null mutants lack a notochord (George et al. 1993) ; α5β1 integrin mediates cell-ECM interactions with fibronectin. In α5 integrin null mutants, notochordal structure is not maintained resulting in the loss of notochordal signals (Goh et al. 1997) . Comparisons between the phenotypic and molecular impact of mutations in these Sox mutants with those arising from loss of function of the individual ECM genes should provide valuable insight into which combinations of ECM proteins work together and are essential for tissue function.
ECM regulation of cartilage development During development, cartilage forms the template for subsequent bone growth in the process of endochondral ossification in which mesenchymal condensation is followed by chondrocyte differentiation, proliferation, and hypertrophy (Kronenberg 2003) . Cartilage is rich in ECM, and not surprisingly, the expression of the cartilage ECM genes is under strict genetic control mediated by instructive signals and transcription factors. The critical roles of many ECM proteins such as collagen II, collagen XI, aggrecan, perlecan, and link protein as components of the cartilage ECM, is reflected in the severe skeletal malformation that arises in their absence (Costell et al. 1999; ArikawaHirasawa et al. 1999; Watanabe and Yamada 1999; S.W. Li et al. 1995 S.W. Li et al. , 2001 Y. Li et al. 1995; Watanabe et al. 1994) . SOX proteins play a critical role in directing the biosynthesis of a functional cartilage ECM, since many of these genes are regulated by these SOX factors. Genetic ablation of SOX9 and its partners SOX5 and SOX6 during chondrogenesis results in severe defects in chondrocyte differentiation, ECM production, and consequently endochondral bone formation (Akiyama et al. 2002; Smits et al. 2001) . In Sox9 null mutants, mesenchymal cells fail to condense, chondrocytes fail to differentiate, and ECM gene targets Col2a1, Col9a2, Col11a2, and Acan (Lefebvre et al. 1997; Bridgewater et al. 2003; Han and Lefebvre 2008; Bell et al. 1997) are not expressed (Bi et al. 1999) . Mutations in each of the ECM genes regulated by SOX9 have been shown to impact on cartilage development and are less severe (S.W. Li et al. , 2001 Y. Li et al. 1995; Watanabe et al. 1994) . However, as illustrated by the Col2a1 and Acan mouse mutants, the final phenotype that arises is a consequence of more than the impact of the individual mutant ECM proteins but rather the abnormal ECM that arises from the downstream effects on other components (Wai et al. 1998; So et al. 2001; Aszodi et al. 1998) . The molecular consequence of the loss of Sox9 function also highlights the critical role of the ECM for chondrogenesis and reveals the collective contribution of multiple ECM components.
This ECM supports chondrocyte adhesion and proliferation through binding to the cell surface adhesion molecule β1 integrin (Aszodi et al. 2003) . The ECM also integrates several signaling pathways. Cartilage ECM regulates fibroblast growth factor (FGF) signaling (Arikawa-Hirasawa et al. 1999 ) and the diffusion of the morphogen ligand Indian hedgehog (IHH; Cortes et al. 2009 ; Fig. 1a, Table 1 ), which coordinates the cartilage-to-bone transition through regulating the differentiation of collagen-X-expressing hypertrophic chondrocytes and collagen-I-expressing osteoblast (Hu et al. 2005; Rodda and McMahon 2006) . Bone morphogenetic protein (BMP) signaling and its regulation of downstream targets such as SOX9 also play a crucial role in this process. Cartilage development is severely compromised in BMP receptor null mutants (Yoon et al. 2005 ). Thus, a complex genetic network dictates ECM gene expression and organization, which in turn regulates the signaling pathways to coordinate the process of cartilage and bone formation.
Organizing developmental cascades at the neuromuscular junction
The neuromuscular junction (NMJ) is a specialized synapse between a motor neuron and an effector muscle fiber for controlling muscle contraction. Recent studies employing multiple mouse models indicate that differentiation of the NMJ depends on the cooperation of extracellular organizers including both the signaling and ECM modules, and that they act in a coordinated manner to exert both cell-type and stage-specific effects. Motor neuronal FGF 7/10/22 signaling via their receptor FGFR2b and the collagen α2(IV) chain contribute to pre-synaptic vesicle clustering during embryonic NMJ formation, whereas laminin α4, α5, and β2 subunits are required for pre-and post-synaptic maturation during the postnatal period. Post-weaning maintenance of NMJ is mediated by the collagen IV isoform (Fox et al. 2007; Nishimune et al. 2008 ). Other stage-specific ECM organizers including laminin-211, perlecan, and agrin cooperatively mediate acetylcholine receptor clustering on the postsynaptic membrane (Smirnov et al. 2005 ; Table 1), a process that is also critical for NMJ maturation and is further fine-tuned by WNT3 signaling both in vitro and in vivo (J. Henriquez et al. 2008 ). In addition, the myelination of peripheral axons by Schwann cells is a process that requires the laminin γ1 chain (Chen and Strickland 2003; Yu et al. 2005 ; Table 1 ).
Epithelial-mesenchymal crosstalk: integration of ECM and morphogen signals
A reciprocal interaction between adjacent epithelial and mesenchymal tissues represents a recurrent mechanism in embryonic tissue morphogenesis and organogenesis. The two compartments generate and receive signals from each other to propagate morphogenesis through regulating cellular proliferation, differentiation, and survival. Given the diverse tissue forms and functions that can be generated by epithelial-mesenchymal crosstalk, the major signaling pathways including BMP, FGF, WNT, Hedgehog, and growth factors such as platelet-derived growth factor (PDGF) are, somewhat surprisingly, recurrently employed to direct tissue-specific gene expression and morphogenesis. Recent findings indicate that ECM molecules also participate in the crosstalk by directly transducing signals through binding with cell surface receptor such as integrin, and that this participation is essential for developmental process.
Laminin α5 chain promotes hair follicle development
Hair follicle morphogenesis begins at 14.5 dpc with the downward invagination of the skin epidermis into the underlying dermis to form a hair placode. This process is dependent on reciprocal signaling between the epidermis (of undifferentiated keratinocytes) and the underlying mesenchymal condensate, which will become the dermal papilla. This papilla will develop into a signaling center to support hair follicle development and to regulate hair production. Laminin-integrin interaction in the epidermal BM has recently been shown to be required for the maintenance of the dermal papilla and hair follicle downgrowth (Gao et al. 2008) . Consistently, in mice lacking integrin-linked kinase (linking integrin to the cytoskeleton) in keratinocytes, hair follicle development is severely impaired at an extremely early stage (Nakrieko et al. 2008) . Laminin-511 is absolutely required for hair follicle development (J. Li et al. 2003 ) through binding to β1 integrin on mesenchymal cells, subsequently inducing primary cilia formation to receive PDGF and SHH from the epidermal cells. The mesenchymal cells also express and secrete Noggin to inhibit BMP signaling in the epidermal cells. Such an inhibition is required to facilitate canonical WNT signaling to promote SHH secretion to the dermal papilla mesenchyme, thus forming a positive feedback loop to support hair follicle development (Gao et al. 2008 ). Laminin-511, therefore, plays a key role in initiating complex signaling crosstalk between the epithelium and the mesenchyme leading to hair morphogenesis (Fig. 1d) .
Branching morphogenesis of submandibular salivary gland, lung, and kidney
Branching is an important patterning process required for the development of many vertebrate organs, including the submandibular salivary gland (SMG), lung, and kidney. The branching structure is generated by repetitive bifurcations of epithelial outgrowths mainly regulated by epithelial-mesenchymal crosstalk.
In SMG branching morphogenesis, a crosstalk scenario between morphogens and laminins is emerging. SMG development begins at around 11.5 dpc, when the epithelium under the tongue starts thickening to form a bud which then undergoes successive rounds of expansion and branching to form multiple cords and buds (Hoffman et al. 2002; Sakai et al. 2003) . FGFR2b expressed in branching epithelium and its corresponding ligand FGF10 (and to a lesser extent FGF8) in the mesenchyme are indispensable for SMG development, the stimulation of bud elongation, and epithelial cell proliferation in addition to branching (Steinberg et al. 2005; Jaskoll et al. 2004b Jaskoll et al. , 2005 Min et al. 1998; Sekine et al. 1999; Entesarian et al. 2005; De Moerlooze et al. 2000) . Both laminin α1 and α5 chains are present in the BM of the developing epithelium, and the latter is required for branching and lumen formation (Rebustini et al. 2007 ). The function of laminin α5 is most likely mediated through integrins α3β1 and α6β1, since blockage of β1 integrin binding or embryos lacking both integrin α3 and α6 display similar phenotypes (Rebustini et al. 2007 ). Importantly, reduced expression of Fgfr1, Fgfr2b, and Fgf1 is observed in Lama5 -/-SMG , suggesting that laminin α5 and FGFs form a positive feedback loop to promote SMG development (Rebustini et al. 2007 ). Moreover, PDGF induces expression of FGF1, FGF3, FGF7, and FGF10 in mesenchyme (Yamamoto et al. 2008) . SHH (Jaskoll et al. 2004a; Hashizume and Hieda 2006) , BMP7 (Hoffman et al. 2002; Jaskoll et al. 2002) , and epidermal growth factor (EGF) (Jaskoll and Melnick 1999) signaling have also been implicated in SMG branching morphogenesis, although no evidence of crosstalk among these pathways has as yet been presented.
The bronchial tree network in the mammalian lung is the end product of repetitive branching operations that have recently been classified into three genetically programmed branching modes (Metzger et al. 2008 ). FGF10-FGFR2b epithelial-mesenchymal signaling is again a central component for lung branching and also lung bud formation from the ventral side of foregut endoderm (for a review, see Cardoso and Lu 2006) . Fgf10 is expressed in the distal mesenchyme, and Fgfr2b is expressed throughout the lung epithelium (Cardoso and Lu 2006) . Similar to early hair follicle and SMG development, BMP4, SHH, and WNT7b signaling have also been implicated in early lung branching morphogenesis (Cardoso and Lu 2006) , although ECM involvement has not been shown in vivo. In vitro functional blocking experiments have shown that antibodies against laminin-111, β1 chain, or γ1 chain interfer with branching in lung bud explants (Schuger et al. 1990a (Schuger et al. , 1990b (Schuger et al. , 1991 . Since mouse embryos lacking any one of the laminin-111 chains die before lung bud formation, the effect of laminin-111 on lung branching needs to be addressed with conditional-null mutants. In comparison, Lama5
-/-and Lama5 conditional-null mutants display lung abnormalities such as defective lobar septation and epithelial cell differentiation without affecting branching, indicating tissue-specific functions of the various laminin isoforms (Nguyen et al. 2002 (Nguyen et al. , 2005 .
Mammalian metanephric kidney forms through reciprocal signaling between the ureteric bud epithelium and the metanephric mesenchyme (Yu et al. 2004 ). Glial-cell-linederived neurotrophic factor (GDNF) expressed in the mesenchyme and its cognate receptor RET in the epithelium mediate a key signal in the initiation of uteric bud formation in the Wolffian duct and outgrowth into the adjacent metanephric mesenchyme (Costantini and Shakya 2006) . Subsequently, feedback signaling between GDNF and Wnt11 expressed in the epithelial tips regulates branching morphogenesis (Majumdar et al. 2003) . These processes are dependent on Gremlin 1-mediated inhibition of BMP4 signaling in the metanephric mesenchyme (Michos et al. 2007 ). In Grem1-null mice showing increased BMP signaling, Gdnf and Wnt11 expression is downregulated, and uteric bud outgrowth is blocked, resulting in bilateral kidney agenesis (Michos et al. 2004 (Michos et al. , 2007 . Interestingly, mice deficient in the ECM molecule nephronectin (expressed by uteric bud epithelium) or its receptor integrin α8 (expressed in metanephric mesenchyme) also display reduced Gdnf expression and kidney agenesis (Linton et al. 2007) . Whether nephronectin interacts with gremlin 1/BMP4 and regulates BMP signaling in branching morphogenesis remains to be determined; additional ECM molecule(s) are likely to share a redundant role with nephronectin in kidney organogenesis (Linton et al. 2007 ; Table 1 ).
An understanding of the way that the differential composition of the ECM contributes to the activities of the major signaling pathways will deepen our knowledge of the means of accomplishment of tissue morphogenesis and organogenesis with the recurrent use of the same sets of signaling mechanism in a tissue-specific manner. Such information will be invaluable for tissue engineering technology to construct tailor-made organs for regenerative medicine.
ECM modulates morphogen transport and availability
In addition to acting as structural components and sending signals directly to cells through cell surface receptors, accumulating evidence shows that the ECM can also physically interact with signaling molecules and their regulators so as to modulate their availability, signaling range, and binding affinity, thus providing additional levels of regulation for fine-tuning signals from various pathways.
Sequestration and movement of FGF in ECM
The range that signals can cover is an important theme for the major classes of morphogen ligands, including BMPs, FGFs, WNTs, and Hedgehogs, but the manner in which gradients of morphogen concentration and activity are established to give precise developmental/patterning instructions is still not fully understood. A balance of production, activation/inactivation, and degradation (through endocytosis) of the ligands and regulators in the extracellular space may constitute part of the mechanism (Akiyama et al. 2008) . Another part could be the regulation of macromolecular movements in the extracellular space through an affinity with ECM components. HSPGs are common modulators, which may be membrane-tethered (e.g., glypican and syndecan) or ECMbound (e.g., perlecan). They play an essential role in FGF signaling for directly stabilizing FGF-FGFR binding (Ornitz 2000) . Variations in the composition of the heparan sulfate side chain of HSPGs confer affinities for different FGFs: for example, L-iduronic acid residues favor binding to FGF2 but not FGF10 (Jia et al. 2009 ). Moreover, a recently identified mutation in mouse, Fgf9
Eks/+ , has provided in vivo evidence that the high affinity of FGF for HSPG restricts its diffusion range in the ECM; reduced affinity of FGF9 with HSPG in this mutant results in an increased FGF9 signaling range and consequently joint fusion and cranial synostosis (Harada et al. 2009; Murakami et al. 2002) . Perlecan is a known modulator of FGF movement and/or storage in the ECM. It can bind to FGF9 (Melrose et al. 2006) , to FGF2 in cartilage (Smith et al. 2007a ) and in the lens capsule of the eye (Tholozan et al. 2007) , to FGF18 in cartilage (Smith et al. 2007b) , and to FGF10 in the BM of the SMG ). Proteolytic release of FGF2 and FGF10 from perlecan activates FGFR and mitogen-activated protein kinase (MAPK) signaling in ex vivo culture of lens capsule and SMG, respectively (Tholozan et al. 2007; Patel et al. 2007 ), but whether and how these cleavage events are regulated to release the ligand in a timely manner are not known. Perlecan is proposed to be a reservoir for morphogens and growth factors; it is estimated that one perlecan molecule can bind with a maximum of 123 molecules of FGF2 in vitro (Smith et al. 2007a ). The number is likely to be smaller in vivo, since perlecan can also interact with many different signaling molecules. How these different and potentially competing interactions between ECM and signaling molecules are modulated in development is an important and challenging area of research for the future.
ECM-mediated fine tuning of BMP signaling
The strength and range of morphogens must be tightly regulated for proper morphogenesis to occur, and cell surface receptors and the ECM have been implicated in shaping the extracellular morphogen gradient by influencing their spread. One of the most characterized signaling gradients is that of BMP, which is essential for development and is crucial for morphogenesis in most if not all tissues. Its regulatory network has evolved into a stunning system comprising a plethora of intracellular and extracellular components differentially expressed in a tissue-specific manner to modulate the range and strength of signaling. Gastrulating Xenopus embryos serve as an outstanding model to illustrate the way that the different members of the BMP family and their regulators, such as Chordin, Noggin, Twisted Gastrulation (TSG), and Crossveinless-2 (CV2), control dorso-ventral patterning (Ambrosio et al. 2008; Bier 2008) . In mouse skeletogenesis, CV2 and TSG cooperate to establish a BMP morphogenetic field in the developing vertebral/intervertebral regions, probably by concentrating TSG/BMP4 complexes in the vertebral body cartilage (Zakin et al. 2008; Ikeya et al. 2008) .
BMPs exhibit direct affinity for intact ECM proteins, such as the structural collagens. A conserved BMP-binding domain has been identified in both invertebrate and vertebrate genes encoding collagen IV chains (X. . Studies in the Drosophila embryo have suggested that binding of a Dpp/Scw heterodimer (the orthologs of BMP) to collagen IV facilitates the assembly of an inhibitory complex in the presence of Sog (the ortholog of Chordin), thereby decreasing BMP signaling activity, whereas in the absence of Sog, collagen IV promotes Dpp/Scw-receptor interactions leading to activation of the BMP signaling pathway. BMP also interacts with procollagen IIA via its cysteine-rich domain (Larrain et al. 2000; Zhu et al. 1999) . Previous studies have demonstrated that overexpressing procollagen IIA induces a secondary body axis in Xenopus embryos, suggesting a role as a BMP antagonist (Larrain et al. 2000) . In contrast, studies in IIAnull mice have revealed that procollagen IIA probably facilitates BMP signaling during heart development (Cheah et al. 2005 ; S.Y.Y. Wong and K.S. Cheah, unpublished). Therefore, the effect of collagens IIA and IV on BMP signaling is most likely context-dependent. It will be a challenging task to determine whether collagens IIA and IV and other BMP-binding proteins co-localize during development and can interact with each other or with other ECM proteins to regulate BMP signaling in vivo. BMP signaling is essential for inner ear development (Pujades et al. 2006; H. Li et al. 2005; Chang et al. 2008 ) when SOX9 and collagen II are expressed in the sensory and nonsensory epithelia of the developing inner ear, which contain BMs and collagen IV (Mak et al. 2009; Khetarpal et al. 1994; Chang et al. 2008; Lui et al. 1995) . Thus, this will be an interesting anatomical site to test whether the ECM components interact and modulate BMP signaling.
Fibrillins also exhibit an affinity for BMP and TGFβ and regulate their bioavailability (Ramirez and Sakai 2009 ). Fibrillins are large cysteine-rich glycoproteins that constitute the backbone of microfibrils that may or may not be associated with elastic fibers. BMPs can be targeted directly to microfibrils through non-covalent interactions between their pro-domains and the N-terminal of fibrillin-1 and fibrillin-2 (Sengle et al. 2008) . Genetic interaction between fibrillin-2 and BMP7 is important in limb digit patterning (Arteaga-Solis et al. 2001) , consistent with the colocalization of BMP7 with both fibrillin-1 and -2 in the developing limb (Sengle et al. 2008) . Thus, fibrillins probably differentially regulate BMP signaling in a context-dependent manner, as do the collagens.
Mammalian BMP signaling must be tightly regulated to prevent any undesirable induction of chondrocytic/osteoblastic differentiation leading to ectopic bone formation and ECM mineralization. Such regulation may be mediated by matrix Gla protein (MGP), an ECM protein that is expressed by vascular smooth muscle cells, endothelial cells, and chondrocytes; mice lacking MGP display ectopic mineralization in arteries and growth-plate cartilage and die of arterial rupture (Luo et al. 1997) . MGP can inhibit BMP2 and BMP4 signaling through direct binding (Yao et al. 2006 (Yao et al. , 2008 . Intriguingly, expression of MGP (and VEGF) in cultured bovine aortic endothelial cells is indirectly induced by BMP2 and BMP4 in a TGFβ/activin-receptorlike kinase-1-dependent manner, suggesting that a regulatory negative feedback loop controls the level of BMP activity to facilitate angiogenesis while preventing vascular mineralization (Yao et al. 2006) . Overexpression of MGP in lung impairs BMP4 expression and subsequent signaling, resulting in defects in pulmonary vascular development (Yao et al. 2007 ). However, whether the arterial mineralization in MGP null mice is attributable to enhanced BMP signaling remains to be determined. Nonetheless, these observations suggest that BMPs not only interact with the ECM, but can also regulate the activities of ECM components, a flexible strategy for fine-tuning signaling range and strength to accommodate changing developmental requirements.
ECM provides microenvironment for stem/progenitor cells
Stem cells are characterized by their ability to self-renew and differentiate into different specialized cell types, thus playing important roles in development and tissue maintenance. The potential of neural stem cells in the treatment of various neurological diseases has, in recent years, been the focus of studies aiming to understand the factors both extrinsically and intrinsically involved in controlling their maintenance, proliferation and differentiation into one of the three cell types of the CNS (neurons, astrocytes, and oligodendrocytes). Multipotent neural stem cells have been isolated from several regions of the CNS including the subventricular zone (Reynolds and Weiss 1992) , the hippocampus , the cerebellum (Laywell et al. 2000) , and the spinal cord (Kalyani et al. 1997; Laywell et al. 1999) . The proliferative and differentiation capacity of neural stem cells in each region is thought to be determined by the factors present in their surrounding environments, termed their "niche", including growth factors and the ECM (Fig. 1c) . Laminin and fibronectin are two important ECM molecules secreted by cells in the niche and have been implicated in neural stem cell growth, differentiation, and migration (Flanagan et al. 2006; Novak and Kaye 2000) . These proteins function as a permissive substrate in promoting the proliferation and differentiation of mouse neuroepithelial cells (Drago et al. 1991) and the migration of cerebellar neural precursor cells in vitro (Kearns et al. 2003) , and the migration of neural precursors through the mouse rostral migratory stream in vivo (Murase and Horwitz 2002) . Several in vitro studies indicate a critical role of β1-integrin signaling in mediating the effects of the ECM on neural stem cells in a timely and spatially controlled manner. In a model system of neurosphere cell cultures, genetic ablation of β1-integrin function results in reduced neural progenitor proliferation and increased cell death and in the impairment of cell migration on different ECM substrates, suggesting a crucial role of β1-integrin-mediated cell-ECM interaction in the regulation of progenitor cell proliferation, survival, and migration (Andressen et al. 1998; Leone et al. 2005) .
Chondroitin sulfate proteoglycans (CSPGs) are also present in the microenvironment of neural stem cells both during development and in the adult neural stem cell niche (Sugahara and Mikami 2007) . Treatment of neurospheres or telencephalic ventricle with enzymes that degrade the CSPG glycosaminoglycans leads to reduced cell proliferation and a diminution of self-renewing radial glial cells and to increased astrocyte formation at the expense of neuronal differentiation, suggesting a role for CSPG in controlling neural stem/progenitor cell proliferation and neuron-glial cell lineage selection (Sirko et al. 2007 ). Moreover, spatial temporal regulation of sulfation on chondroitin sulfate polymers modulates the activities of various growth and morphogenetic factors in the control of neural stem cell proliferation, maintenance, and differentiation (Akita et al. 2008; Esko and Selleck 2002) . Interaction with the ECM therefore plays a critical role in maintaining the multipotency and migratory capacity of neural stem cells.
An ECM-morphogen interaction is also important in maintaining the stem cell niche. In the germarium of the Drosophila ovary, collagen IV binds to BMP and restricts its movement, thereby promoting short-range BMP signaling to inhibit germline stem cell differentiation (X. .
In mammalian tendon, biglycan and fibromodulin are involved in organizing the niche for tendon stem/progenitor cells. In double-null mice lacking both biglycan and fibromodulin, the micro-environment of these cells is altered such that BMP signaling increases locally to favor chondrocytic/osteoblastic differentiation and hence ectopic endochondral bone formation, thereby impairing tendon formation in the young adult (Bi et al. 2007) . Biglycan may act with decorin to organize the niche for maintaining bone marrow stromal cells (Bi et al. 2005) . Mice are osteopenic in the absence of both biglycan and decorin, which may be attributable to increased TGFβ and BMP signaling resulting in increased apoptotic elimination of bone marrow stromal cells, thus depleting progenitor cells for bone formation (Bi et al. 2005) . In addition to interacting with morphogen ligands, these small proteoglycans and other ECM components might regulate collagen fibrillogenesis, which determines ECM elasticity, thereby affecting cell fate specification as discussed previously. The bone marrow is also an important hematopoietic stem cell niche, the formation of which is dependent on proper endochondral bone formation (Chan et al. 2009 ); the niche is suggested to associate with collagen X and perlecan expression in hypertrophic cartilage (Sweeney et al. 2008; Rodgers et al. 2008) . Since the ECM molecules are present in various combinations in vivo, we urgently need to evaluate the cellular responses to the composition of the ECM in order to clarify the role of stem cell-substrate interactions during histogenesis. Greater knowledge of this will facilitate the development of bioartificial grafts to improve graft stem/ progenitor cell integration and tissue regeneration.
Concluding remarks
The enormous range of possible interactions between a wide variety of secreted molecules and ECM components has produced an extensive repertoire of "net" signals that can be generated in the extracellular space. This pleiotropy has permitted the evolution of a great diversity of tissue structures and functions. Animal models help us to explore these relationships and their outcomes and show the dynamic nature of the cell-ECM interaction and tissue morphogenesis under the influence of genetically programmed development. Such models are irreplaceable tools for us to understand the biology of the ECM in vivo.
However, for a number of ECM proteins, loss of function models has not revealed a developmental role, but this does not imply a lack of function. Rather such function may be masked by redundancy or compensation by other ECM molecules, or because the functional role is part of an interacting complex. Gain of function or dominant negative mutations in mice and humans may provide insights into developmental roles fulfilled by combinations of ECM proteins that work together. As is increasingly evident, the ECM plays important roles in modulating the availability of morphogens and growth factors. Further discoveries and molecular insights into the role of the ECM in controlling the ligand-receptor interactions and signaling activity can be expected. The fruits of the International Knockout Mouse Consortium (Gondo 2008) will certainly enrich and expedite a deeper understanding of the functional roles of the many ECM proteins. These insights will advance our understanding of the molecular pathology of connective tissue diseases and also contribute to regenerative medicine in which knowledge of tissue morphogenesis and organogenesis are critical for devising practical therapeutic strategies.
Box 1: introduction to some basic ECM molecules and structures
Collagens
Collagens are triple helical proteins that confer compressive and tensile strength to animal tissues and serve as anchors for cell adhesion through surface receptors. To date, more than 40 mammalian genes encoding collagen α chains have been described, the products of which combine to form at least 28 distinct homo-and heterotrimeric molecules Heino 2007; Gordon and Hahn 2009 ). The collagen proteins differ considerably in size, structure, tissue distribution, and function, but all are characterized by the presence of either continuous or interrupted triple-helical domains made up of repeating Gly-X-Y motifs. Collagen subfamily members form different supramolecular structures such as fibrils (collagens I, II, III, V, XI, XXIV, and XXVII), non-fibrillar networks (collagen IV), and lattices (collagens VIII and X). Other subfamilies include fibril-associated collagens (collagens VII, IX, XII, XIV, XVI, XIX, XX, XXI, and XXII) and transmembranous collagens (collagen XIII, XVII, XXIII, and XXV).
Proteoglycans
Proteoglycans (PGs) consist of a diverse group of core proteins to which sulfated glycosaminoglycan (GAG) side chains are covalently linked. The GAG chains can be classified as keratin sulfate, chondroitin sulfate (CS), dermatan sulfate, and heparan sulfate (HS; Bulow and Hobert 2006) . PGs can be secreted or cell-surface bound and serve diverse functions including ECM assembly and mediating cell adhesion and motility. PGs can be generally classified according to the major GAG chains they carry. For example, perlecan is classified as HSPG but may also carry a CS chain, especially when expressed in cartilage in which the CS may modulate FGF signaling (Smith et al. 2007a ).
Basement membrane, laminin, and collagen IV Basement membrane (BM) is a specialized ECM comprising laminins and collagen IV networks as central structural components, and nidogens and PGs. It is present in many tissues and serves as a barrier and structural support. Diversity of BM structure is partly derived from the large numbers of differentially expressed isoforms of laminins. Laminin isoforms are a family of 15 multidomain heterotrimeric glycoproteins, each assembled from a combination of five α, three β, and three γ chains (Nguyen and Senior 2006) . The nomenclature for the laminins is based on chain numbers, e.g., laminin composed of α3β3+2, formerly known as laminin-5, is now called laminin-332 (Aumailley et al. 2005) . Collagen IV is a heterotrimeric protomer of three isoforms with the "classic" isoform α1 2 α2(IV) present in BM of most tissues (Yurchenco et al. 2004; Khoshnoodi et al. 2008) . 
